Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00886626
What this trial is testing

GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children

Who this might be right for
Obesity, Morbid
University of Minnesota 12
Not applicableNot Yet RecruitingNCT07014709
What this trial is testing

Impact of GLP-1 Receptor Agonists on Patients With IPMN

Who this might be right for
IPMNIPMN, PancreaticGLP-1+2 more
Hôpital Fribourgeois 30
Not applicableUnknownNCT04186026
What this trial is testing

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Who this might be right for
Obesity
University of Copenhagen 35
Early research (Phase 1)Study completedNCT02094521
What this trial is testing

Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 122
Early research (Phase 1)Study completedNCT04779697
What this trial is testing

GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

Who this might be right for
Obesity
Yale University 96
Not applicableStudy completedNCT00247455
What this trial is testing

Fibre and Appetite Regulation Trial (FART)

Who this might be right for
ObesityDiabetes
University of Toronto 32
Not applicableStudy completedNCT00884091
What this trial is testing

A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects

Who this might be right for
Healthy
Taipei Veterans General Hospital, Taiwan 21
Large-scale testing (Phase 3)Study completedNCT05680155
What this trial is testing

Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Who this might be right for
T2DMType 2 Diabetes Mellitus
Hangzhou Sciwind Biosciences Co., Ltd. 211
Early research (Phase 1)Not Yet RecruitingNCT07140055
What this trial is testing

A Research Study to Evaluate BLX-7006 in Healthy Adults

Who this might be right for
Normal Healthy VolunteerSafety After Oral Intake
Biolexis Therapeutics 76
Not applicableStudy completedNCT01779622
What this trial is testing

Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers

Who this might be right for
Healthy Volunteers Recruited From the General Population
Lund University 24
Not applicableNot Yet RecruitingNCT07175805
What this trial is testing

Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy

Who this might be right for
Lower Urinary Tract SymptomsStress Urinary IncontinenceUrge Urinary Incontinence+6 more
Hartford HealthCare 200
Not applicableStudy completedNCT06236672
What this trial is testing

Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Type 2 DiabetesChronic Kidney Diseases
LMC Diabetes & Endocrinology Ltd. 348
Testing effectiveness (Phase 2)Study completedNCT07281937
What this trial is testing

Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweight
Verdiva Bio Dev Limited 206
Testing effectiveness (Phase 2)Looking for participantsNCT06994338
What this trial is testing

Tirzepatide for Alcohol Use Disorder

Who this might be right for
Alcohol Use DisorderObesity and OverweightAlcohol
University of Southern California 42
Testing effectiveness (Phase 2)Study completedNCT06693843
What this trial is testing

A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
Obesity, Overweight, or Chronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 230
Not applicableUnknownNCT05569304
What this trial is testing

Endoscopic Sleeve Gastroplasty Versus GLP-1 Analogue for Class 1 and 2 Obesity Study

Who this might be right for
Obesity
Sengkang General Hospital 66
Testing effectiveness (Phase 2)Looking for participantsNCT06811324
What this trial is testing

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults

Who this might be right for
Obesity PreventionSarcopenia in ElderlyCardiovascular Function+2 more
The University of Texas Health Science Center at San Antonio 20
Very early researchStudy completedNCT01453842
What this trial is testing

Diet Oil Induced Stimulation of GLP-1

Who this might be right for
Type 2 Diabetes Mellitus
University of Copenhagen 12
Testing effectiveness (Phase 2)Looking for participantsNCT06548490
What this trial is testing

GLP-1R Agonist Treatment for Opioid Use Disorder

Who this might be right for
Opioid Use DisorderOpioid Abuse and AddictionNarcotic-Related Disorders+4 more
Milton S. Hershey Medical Center 200
Not applicableNot Yet RecruitingNCT06659159
What this trial is testing

Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying

Who this might be right for
Pulmonary Aspiration During Anaesthetic Induction
Sascha Battig 50
Next Page